Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/105205

Títol:	PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.
Autor/a:	Cordeiro Santanach, Anna; Navarro Ponz, Alfons; Gaya, Anna; Díaz Beyá, Marina; Gonzalez Farré, Blanca; Castellano, Joan Josep; Fuster, Dolors; Martínez, Carmen; Martínez Pozo, Antonio; Monzó Planella, Mariano
Altres autors:	Universitat de Barcelona
Abstract:	PiwiRNAs, small non-coding RNAs processed by Piwi proteins, are involved in maintaining genome stability in germline cells. Recently, piwiRNA expression has been identified in some tumors. We have examined the potential reactivation of the Piwi/piwiRNA pathway in classical Hodgkin lymphoma (cHL). We found that Piwi proteins and three selected piwiRNAs, including piR-651, were expressed in cHL patients and cell lines, indicating that the Piwi/piwiRNA pathway is active in cHL. Interestingly, low levels of piR-651 were associated with lack of complete response to first-line treatment, as well as shorter disease-free and overall survival in a cohort of 94 cHL patients. At diagnosis, piR-651 was underexpressed in cHL serum samples compared to healthy controls, while after complete remission, piR-651 levels increased to levels similar to healthy controls. This is the first evidence that piwiRNAs are active in tumor and serum samples and impact prognosis in cHL.
Matèries:	-Malaltia de Hodgkin -Limfomes -Micro RNAs -Hodgkin's disease -Lymphomas -MicroRNAs
Drets:	cc-by (c) Cordeiro, Anna et al., 2016 http://creativecommons.org/licenses/by/3.0/es
Tipus de document:	Article Article - Versió publicada
Publicat per:	Impact Journals
Compartir:

Mostra el registre complet del document